Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

NIH 5NETWORK 4OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma 19Lymphoma, Large B-Cell, Diffuse 17Hodgkin Disease 8Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 5Leukemia 5Hemangioma 5Lymphoma, Large-Cell, Anaplastic 4Prostatic Neoplasms 3Neoplasms 3Lymphoma, B-Cell 3Immunoblastic Lymphadenopathy 3Neurotoxicity Syndromes 2Neoplasm, Residual 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Esophageal Stenosis 2Enteropathy-Associated T-Cell Lymphoma 2Vomiting 1Thymoma 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Polycystic Ovary Syndrome 1Philadelphia Chromosome 1Neoplasm Metastasis 1Neoadjuvant Therapy 1Nausea 1

Interventions

Cyclophosphamide 160Rituximab 82Peripheral Blood Stem Cell Transplantation 78fludarabine phosphate 75Etoposide 69Filgrastim 67Methotrexate 59Cytarabine 58Vincristine 50Mycophenolic Acid 50Whole-Body Irradiation 48Radiotherapy 43Cyclosporine 43Busulfan 42Tacrolimus 40Melphalan 39Dexamethasone 37Prednisone 36Doxorubicin 36Antilymphocyte Serum 36fludarabine 31blinatumomab 27Methylprednisolone 24Granulocyte Colony-Stimulating Factor 22Carmustine 22Cord Blood Stem Cell Transplantation 21Calcium Dobesilate 18CT-P10 18Inotuzumab Ozogamicin 16sargramostim 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Burkitt Lymphoma × Prednisolone × Clear all
NCT00199082 2022-08-19

Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults

Goethe University

Phase 4 Completed
650 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Mediastinal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡